DSP-0565

N/A

Report date: 2022/06/30 14:39:17
NME

Base Information

Drug NameDSP-0565
Drug Alias NameDSP-0565
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channelSodium channels
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Dainippon
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A